Hokkaido, Japan

Ikuo Saiki


Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 64(Granted Patents)


Location History:

  • Hokkaido, JP (1993)
  • Fuchu-machi, JP (2003)

Company Filing History:

goldMedal3 out of 832,966 
Other
 patents

Years Active: 1993-2003

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ikuo Saiki: Innovator in Immunosuppressive Agents and Polypeptides

Introduction

Ikuo Saiki is a prominent inventor based in Hokkaido, Japan. He has made significant contributions to the field of immunology and biotechnology, holding a total of 3 patents. His work focuses on developing innovative solutions for treating various medical conditions.

Latest Patents

One of Ikuo Saiki's latest patents is for an immunosuppressive agent that is highly effective in treating autoimmune diseases, inflammatory reactions, and related conditions. This agent selectively inhibits activated T cells, making it a promising treatment for tissue injury, infection, transplantation rejection, graft versus host disease, and allergic diseases. Another notable patent involves a polypeptide comprising repeated amino acid sequences of a cell-adhesive protein, which has potential applications in cell adhesion and tissue engineering.

Career Highlights

Throughout his career, Ikuo Saiki has demonstrated a commitment to advancing medical science through his innovative inventions. His research has contributed to a better understanding of immune responses and has opened new avenues for therapeutic interventions.

Collaborations

Ikuo Saiki has collaborated with notable colleagues, including Norio Nishi and Ichiro Azuma. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking technologies.

Conclusion

Ikuo Saiki's contributions to the fields of immunology and biotechnology highlight his role as a leading inventor. His innovative patents continue to pave the way for advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…